BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38490370)

  • 1. Risk of systemic lymphoma in patients with cutaneous CD30+ lymphoproliferative disorders: A single center retrospective cohort analysis.
    Chen J; Martinez A; Shinohara MM
    J Am Acad Dermatol; 2024 Mar; ():. PubMed ID: 38490370
    [No Abstract]   [Full Text] [Related]  

  • 2. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
    Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
    Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma.
    Liu HL; Hoppe RT; Kohler S; Harvell JD; Reddy S; Kim YH
    J Am Acad Dermatol; 2003 Dec; 49(6):1049-58. PubMed ID: 14639383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies.
    Wada DA; Law ME; Hsi ED; Dicaudo DJ; Ma L; Lim MS; Souza Ad; Comfere NI; Weenig RH; Macon WR; Erickson LA; Ozsan N; Ansell SM; Dogan A; Feldman AL
    Mod Pathol; 2011 Apr; 24(4):596-605. PubMed ID: 21169992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders.
    Sciallis AP; Law ME; Inwards DJ; McClure RF; Macon WR; Kurtin PJ; Dogan A; Feldman AL
    Mod Pathol; 2012 Jul; 25(7):983-92. PubMed ID: 22388754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
    Kempf W; Pfaltz K; Vermeer MH; Cozzio A; Ortiz-Romero PL; Bagot M; Olsen E; Kim YH; Dummer R; Pimpinelli N; Whittaker S; Hodak E; Cerroni L; Berti E; Horwitz S; Prince HM; Guitart J; Estrach T; Sanches JA; Duvic M; Ranki A; Dreno B; Ostheeren-Michaelis S; Knobler R; Wood G; Willemze R
    Blood; 2011 Oct; 118(15):4024-35. PubMed ID: 21841159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric oral Epstein-Barr virus associated self-remitting CD30+ lymphoproliferative disorder: A distinct entity.
    Schwartz Z; Bowe RB; Coleman M; Magro CM
    Ann Diagn Pathol; 2018 Dec; 37():57-61. PubMed ID: 30292067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease.
    Wood GS; Hardman DL; Boni R; Dummer R; Kim YH; Smoller BR; Takeshita M; Kikuchi M; Burg G
    Blood; 1996 Sep; 88(5):1765-70. PubMed ID: 8781433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of the CD30 promoter microsatellite repressive element is associated with development of primary cutaneous lymphoproliferative disorders.
    Franchina M; Kadin ME; Abraham LJ
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1322-5. PubMed ID: 15894695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD30+ lymphoproliferative disorder: primary cutaneous anaplastic large cell lymphoma followed by lymphomatoid papulosis.
    Aoki M; Niimi Y; Takezaki S; Azuma A; Seike M; Kawana S
    Br J Dermatol; 2001 Jul; 145(1):123-6. PubMed ID: 11453920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
    Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
    Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical Management of CD30⁺ Lymphoproliferative Disorders.
    Hughey LC
    Dermatol Clin; 2015 Oct; 33(4):819-33. PubMed ID: 26433852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype.
    Kummer JA; Vermeer MH; Dukers D; Meijer CJ; Willemze R
    J Invest Dermatol; 1997 Nov; 109(5):636-40. PubMed ID: 9347791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of CD30+ lymphoid proliferations in the eyelid lymphomatoid papulosis, cutaneous anaplastic large cell lymphoma, and anaplastic large cell lymphoma.
    Sanka RK; Eagle RC; Wojno TH; Neufeld KR; Grossniklaus HE
    Ophthalmology; 2010 Feb; 117(2):343-51. PubMed ID: 19969358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Cutaneous CD30+ Lymphoproliferative Disorders: a Comprehensive Review.
    Di Raimondo C; Parekh V; Song JY; Rosen ST; Querfeld C; Zain J; Martinez XU; Abdulla FR
    Curr Hematol Malig Rep; 2020 Aug; 15(4):333-342. PubMed ID: 32435988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders.
    Abdulla FR; Zhang W; Wu X; Honda K; Qin H; Cho H; Querfeld C; Zain J; Rosen ST; Chan WC; Parekh V; Song JY
    JID Innov; 2022 Jan; 2(1):100068. PubMed ID: 34977845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spectrum of CD30+ T cell lymphoproliferative disorders in the skin.
    Kartan S; Johnson WT; Sokol K; Alpdogan O; Gru AA; Nikbakht N; Porcu P
    Chin Clin Oncol; 2019 Feb; 8(1):3. PubMed ID: 30691273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous CD30+ lymphoproliferative disorders with DUSP22 translocation.
    Montes-Moreno S
    Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):136-139. PubMed ID: 38010388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated CD8-positive, CD30-positive cutaneous lymphoproliferative eruption with overlapping features of mycosis fungoides and primary cutaneous anaplastic large cell lymphoma following remote solitary lesional presentation.
    Davick JJ; Mutgi KAJ; Wanat KA; Link BK; Liu V
    J Cutan Pathol; 2017 Aug; 44(8):703-712. PubMed ID: 28497585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Associated Lymphomas and Their Risk Factors in Patients with Lymphomatoid Papulosis: A Retrospective Single-Center Study from Turkey.
    Baykal C; Kılıç Sayar S; Yazganoğlu KD; Büyükbabani N
    Turk J Haematol; 2021 Feb; 38(1):49-56. PubMed ID: 33389922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.